While only 2 studies found opposite results and stated that COX-2 expression is more common in normal and benign lesions of the breast compared with BC, and the remaining studies did not investigate COX-2 immunoexpression in normal tissue and benign lesions of the breast.21,22. The gene discussed is PTGS2; the disease is breast cancer.